Nephrology drug pipeline

CKD, ESRD, transplant rejection, IgA nephropathy, and other kidney-disease therapeutics.

Recent approvals (last 30 days)

No approvals in this window.

Upcoming PDUFA dates (next 6 months)

No upcoming decisions in this window.

Top sponsors

1. · 32 drugs
2. Genzyme, a Sanofi Company · 4 drugs
3. GlaxoSmithKline · 3 drugs
4. Vantive Health LLC · 3 drugs
5. Provepharm Sas · 3 drugs
6. Henan University of Traditional Chinese Medicine · 2 drugs
7. Jennifer Gassman, PhD · 2 drugs
8. Abbott · 2 drugs
9. Chinese PLA General Hospital · 2 drugs
10. Astellas Pharma Inc · 2 drugs

Key drug classes

• Peritoneal dialysis solution · 7
• Phosphate binder · 7
• Vitamin D analog · 5
• HIF prolyl hydroxylase inhibitor · 3
• SGLT2 inhibitor · 3
• erythropoiesis-stimulating agent · 3
• Calcimimetic agent · 3
• Vitamin D receptor agonist · 3
• Potassium binder · 2
• Urinary alkalinizing agent · 2
• Non-steroidal mineralocorticoid receptor antagonist · 2
• Adrenocorticotropic Hormone [EPC] · 2
• Estrogen · 2
• Antioxidant polyphenol · 1
• Antioxidant / Mucolytic agent · 1

Subscribe

Get nephrology approvals + PDUFA dates in your RSS reader:

• Nephrology RSS feed · Atom · JSON

Other therapeutic areas